Anika Therapeutics Management
Management criteria checks 2/4
Anika Therapeutics' CEO is Cheryl Blanchard, appointed in Feb 2020, has a tenure of 4.17 years. total yearly compensation is $5.94M, comprised of 11.7% salary and 88.3% bonuses, including company stock and options. directly owns 1.11% of the company’s shares, worth $4.24M. The average tenure of the management team and the board of directors is 3.7 years and 5.1 years respectively.
Key information
Cheryl Blanchard
Chief executive officer
US$5.9m
Total compensation
| CEO salary percentage | 11.7% |
| CEO tenure | 4.2yrs |
| CEO ownership | 1.1% |
| Management average tenure | 3.7yrs |
| Board average tenure | 5.1yrs |
Recent management updates
Recent updates
Is There An Opportunity With Anika Therapeutics, Inc.'s (NASDAQ:ANIK) 44% Undervaluation?
Jan 30
Companies Like Anika Therapeutics (NASDAQ:ANIK) Can Afford To Invest In Growth
Aug 03Anika Therapeutics: New Share Price Low May Imply New Upside Opportunity
Mar 11Are Investors Undervaluing Anika Therapeutics, Inc. (NASDAQ:ANIK) By 48%?
Jun 25Anika Therapeutics (ANIK) Presents At UBS Global Healthcare Virtual Conference - Slideshow
May 28Anika Therapeutics, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 07How Much Are Anika Therapeutics, Inc. (NASDAQ:ANIK) Insiders Taking Off The Table?
Mar 16Anika Therapeutics (NASDAQ:ANIK) Seems To Use Debt Quite Sensibly
Feb 09An Intrinsic Calculation For Anika Therapeutics, Inc. (NASDAQ:ANIK) Suggests It's 32% Undervalued
Jan 13If You Had Bought Anika Therapeutics' (NASDAQ:ANIK) Shares A Year Ago You Would Be Down 21%
Dec 18
Anika Therapeutics, Inc. 2020 Q3 - Results - Earnings Call Presentation
Nov 06CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$83m |
| Sep 30 2023 | n/a | n/a | -US$25m |
| Jun 30 2023 | n/a | n/a | -US$22m |
| Mar 31 2023 | n/a | n/a | -US$22m |
| Dec 31 2022 | US$6m | US$695k | -US$15m |
| Sep 30 2022 | n/a | n/a | -US$16m |
| Jun 30 2022 | n/a | n/a | -US$11m |
| Mar 31 2022 | n/a | n/a | -US$2m |
| Dec 31 2021 | US$4m | US$668k | US$4m |
| Sep 30 2021 | n/a | n/a | -US$6m |
| Jun 30 2021 | n/a | n/a | -US$13m |
| Mar 31 2021 | n/a | n/a | -US$27m |
| Dec 31 2020 | US$10m | US$548k | -US$24m |
| Sep 30 2020 | n/a | n/a | -US$4m |
| Jun 30 2020 | n/a | n/a | US$11m |
| Mar 31 2020 | n/a | n/a | US$28m |
| Dec 31 2019 | US$187k | n/a | US$27m |
| Sep 30 2019 | n/a | n/a | US$31m |
| Jun 30 2019 | n/a | n/a | US$29m |
| Mar 31 2019 | n/a | n/a | US$30m |
| Dec 31 2018 | US$167k | n/a | US$19m |
Compensation vs Market: Cheryl's total compensation ($USD5.94M) is above average for companies of similar size in the US market ($USD2.37M).
Compensation vs Earnings: Cheryl's compensation has increased whilst the company is unprofitable.
CEO
Cheryl Blanchard (59 yo)
4.2yrs
Tenure
US$5,940,722
Compensation
Dr. Cheryl Renee Blanchard, Ph. D. is Director of Elute, Inc. from May 2013. She serves as the President & Chief Executive Officer of Anika Therapeutics, Inc. since April 26, 2020. She serves as Director o...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.2yrs | US$5.94m | 1.11% $ 4.2m | |
| Executive VP | 3.7yrs | US$1.83m | 0.32% $ 1.2m | |
| Executive VP | 4.1yrs | US$1.65m | 0.23% $ 856.2k | |
| Senior VP & COO | 2.6yrs | no data | 0.076% $ 287.7k | |
| VP & Chief Accounting Officer | no data | no data | no data | |
| Executive Director of Investor Relations & Corporate Communications | no data | no data | no data | |
| Senior Vice President of International Sales & Marketing | 3.9yrs | no data | no data | |
| Vice President of Commercial & Corporate Development | 2.3yrs | no data | no data | |
| Vice President of Human Resources | 2.2yrs | no data | no data |
3.7yrs
Average Tenure
54yo
Average Age
Experienced Management: ANIK's management team is considered experienced (3.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 5.7yrs | US$5.94m | 1.11% $ 4.2m | |
| Independent Chair of the Board | 4.7yrs | US$244.99k | 0.16% $ 608.2k | |
| Independent Director | 5.5yrs | US$244.99k | 0.16% $ 617.0k | |
| Independent Director | 2.5yrs | US$239.99k | 0.073% $ 277.1k | |
| Independent Director | 9.2yrs | US$237.49k | 0.16% $ 618.2k | |
| Independent Director | less than a year | no data | 0.016% $ 60.2k | |
| Independent Director | 13.3yrs | US$261.68k | 0.17% $ 650.7k | |
| Independent Director | 3.6yrs | US$241.66k | 0.15% $ 556.3k |
5.1yrs
Average Tenure
61yo
Average Age
Experienced Board: ANIK's board of directors are considered experienced (5.1 years average tenure).